Rose T - Search Results

1

Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.

Gatto M, Wiedemann A, Nomovi N, Reiter K, Schrezenmeier E, Rose T, Szelinski F, Lino AC, Valentino S, Ghirardello A, Dörner T, Doria A. Gatto M, et al. Among authors: rose t. Front Immunol. 2019 Jan 25;10:29. doi: 10.3389/fimmu.2019.00029. eCollection 2019. Front Immunol. 2019. PMID: 30740098 Free PMC article.

2

High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.

Lisney AR, Szelinski F, Reiter K, Burmester GR, Rose T, Dörner T. Lisney AR, et al. Among authors: rose t. Ann Rheum Dis. 2017 Aug;76(8):1476-1480. doi: 10.1136/annrheumdis-2016-210927. Epub 2017 May 13. Ann Rheum Dis. 2017. PMID: 28501799

3

Drivers of the immunopathogenesis in systemic lupus erythematosus.

Rose T, Dörner T. Rose T, et al. Best Pract Res Clin Rheumatol. 2017 Jun;31(3):321-333. doi: 10.1016/j.berh.2017.09.007. Epub 2017 Oct 20. Best Pract Res Clin Rheumatol. 2017. PMID: 29224674 Review.

4

Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.

Aue A, Szelinski F, Weißenberg SY, Wiedemann A, Rose T, Lino AC, Dörner T. Aue A, et al. Among authors: rose t. Rheumatology (Oxford). 2020 Nov 1;59(11):3435-3442. doi: 10.1093/rheumatology/keaa187. Rheumatology (Oxford). 2020. PMID: 32357246

5

[Antinuclear antibodies in the diagnostics of rheumatic diseases].

Rose T, Dörner T. Rose T, et al. Z Rheumatol. 2020 Jun;79(5):447-458. doi: 10.1007/s00393-020-00802-6. Z Rheumatol. 2020. PMID: 32458159 German.

6

Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.

Bertolo M, Baumgart S, Durek P, Peddinghaus A, Mei H, Rose T, Enghard P, Grützkau A. Bertolo M, et al. Among authors: rose t. Front Immunol. 2020 Mar 24;11:256. doi: 10.3389/fimmu.2020.00256. eCollection 2020. Front Immunol. 2020. PMID: 32265898 Free PMC article.

7

SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome.

Rose T, Szelinski F, Lisney A, Reiter K, Fleischer SJ, Burmester GR, Radbruch A, Hiepe F, Grützkau A, Biesen R, Dörner T. Rose T, et al. RMD Open. 2016 Dec 30;2(2):e000292. doi: 10.1136/rmdopen-2016-000292. eCollection 2016. RMD Open. 2016. PMID: 28123773 Free PMC article.

8

Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study.

Rose T, Grützkau A, Klotsche J, Enghard P, Flechsig A, Keller J, Riemekasten G, Radbruch A, Burmester GR, Dörner T, Hiepe F, Biesen R. Rose T, et al. Rheumatology (Oxford). 2017 Sep 1;56(9):1618-1626. doi: 10.1093/rheumatology/kex220. Rheumatology (Oxford). 2017. PMID: 28859328

9

Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry.

Budzinski L, Schulz AR, Baumgart S, Burns T, Rose T, Hirseland H, Mei HE. Budzinski L, et al. Among authors: rose t. J Immunol. 2019 May 15;202(10):3103-3112. doi: 10.4049/jimmunol.1801640. Epub 2019 Apr 15. J Immunol. 2019. PMID: 30988119

10

Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.

Jucaud V, Ravindranath MH, Terasaki PI, Morales-Buenrostro LE, Hiepe F, Rose T, Biesen R. Jucaud V, et al. Among authors: rose t. Clin Exp Immunol. 2016 Mar;183(3):326-40. doi: 10.1111/cei.12724. Epub 2015 Dec 16. Clin Exp Immunol. 2016. PMID: 26440212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

881 results

Search Page